Sign in: Staff/Students
The University of Liverpool is leading a £3 million European consortium to develop the use of particle beam therapy for treating cancer.
The `Optimisation of Medical Accelerators’ (OMA) is a research and training consortium involving 24 institutions from across Europe.
It will train 15 early stage researchers to carry out research into the treatment facility design, numerical simulations for the development of advanced therapies and novel imaging techniques.
Although significant progress has been made in the use of particle beams for cancer treatment, extensive research is still needed to maximise healthcare benefits.
Professor Carsten P. Welsch from the University’s Department of Physics, based at the Cockcroft Institute, will coordinate the consortium.
He said: “The field of particle therapy has steadily developed over the last six decades, first in physics laboratories, and starting in the late 90’s in dedicated clinical installations.
“By March 2013 about 110,000 people had received treatment with particle beams, the vast majority having been treated with protons and around 15,000 patients with heavier ions such as helium, carbon, neon, and argon.”
“OMA will push the limits in treatment facility design, imaging techniques and treatment optimisation through advanced numerical studies.
“A network of European universities, research centres, clinical facilities and industry partners with outstanding expertise in this area will jointly develop advanced schemes to assure the best possible cancer care for patients.”
The University of Liverpool has a proven track record in the coordination of large scale European networks through the successful completion of the DITANET, oPAC and LA3NET projects. OMA will directly build up on the experiences gained within these earlier initiatives and train the next generation of medical accelerator experts.
Professor Welsch added: “I am absolutely delighted that this collaboration has been funded. In close collaboration with our project partners we will provide a broad and interdisciplinary training programme to our Fellows to develop them into outstanding researchers.
“We will also organise many events for the wider research community to stimulate knowledge exchange and generate a lasting impact.”
The project is currently recruiting for its Fellowship positions that will be based at institutions across Europe. Researchers from around the world are invited to submit their application by 28 February 2016. Further information on the vacancies available through the project can be found at: http://www.oma-project.eu/
To find out more about OMA, visit: http://www.oma-project.eu.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 675265.
You must be logged in to post a comment.
All recent news
Lateral flow tests detect most people at risk of transmitting Covid-19
Free digital skills training for Liverpool students
Social disadvantage in the UK has a lasting impact on childhood asthma
Win a year’s tuition fees with Santander Universities UK
How to share your feedback with us – Student Feedback Hub
Professor Eithne Costello from @LivUni on the link between Type 2 Diabetes and Pancreatic Cancer #ITVTonight at 8pm.
Professor Chris Holloran of The University Of Liverpool (@LivUni) explains the importance of diagnosing Pancreatic Cancer early.
You can watch the full episode on #ITVTonight at 8pm
Researchers from @LivCancerRes feature in a new @ITVTonight film about #PancreaticCancer.
Profs Chris Halloran & Eithne Costello discuss the importance of early detection & the research taking place to help to improve outcomes.
📺 Watch 'Britain's Hidden Killer' on ITV at 8pm.